This paper is published in Volume-11, Issue-1, 2025
Area
Diseases And Health
Author
Falakh Jahid
Org/Univ
Vidyashilp Academy, Bengaluru, Karnataka, India
Keywords
Attention Deficit Hyperactivity Disorder, Medication, Behaviour, Treatment, Non-Pharmaceutical, Pharmaceutical
Citations
IEEE
Falakh Jahid. Do Early Medications in Cases of ADHD Help Children to Cope with Behavioural Issues?, International Journal of Advance Research, Ideas and Innovations in Technology, www.IJARIIT.com.
APA
Falakh Jahid (2025). Do Early Medications in Cases of ADHD Help Children to Cope with Behavioural Issues?. International Journal of Advance Research, Ideas and Innovations in Technology, 11(1) www.IJARIIT.com.
MLA
Falakh Jahid. "Do Early Medications in Cases of ADHD Help Children to Cope with Behavioural Issues?." International Journal of Advance Research, Ideas and Innovations in Technology 11.1 (2025). www.IJARIIT.com.
Falakh Jahid. Do Early Medications in Cases of ADHD Help Children to Cope with Behavioural Issues?, International Journal of Advance Research, Ideas and Innovations in Technology, www.IJARIIT.com.
APA
Falakh Jahid (2025). Do Early Medications in Cases of ADHD Help Children to Cope with Behavioural Issues?. International Journal of Advance Research, Ideas and Innovations in Technology, 11(1) www.IJARIIT.com.
MLA
Falakh Jahid. "Do Early Medications in Cases of ADHD Help Children to Cope with Behavioural Issues?." International Journal of Advance Research, Ideas and Innovations in Technology 11.1 (2025). www.IJARIIT.com.
Abstract
Diagnoses of Attention Deficit Hyperactivity disease (ADHD), a common neurodevelopmental disease, have increased globally, especially since the 1980s. Until the late 20th century, ADHD was not as often diagnosed in other parts of the world as it is in Western nations like the United States. This study examines how the prevalence of ADHD diagnoses and medication use is rising across a range of demographics, with a particularly noticeable increase seen between 2005 and 2012. The study lists the main causes of ADHD, which include environmental variables, brain damage, prenatal substance exposure, and genetic factors. Although environmental variables including low birth weight and exposure to pollutants certainly play a part, genetics is the primary determinant, with heritability estimates ranging from 70 to 90%. Individuals of all ages are impacted by the wide-ranging effects of ADHD. Among these are increased chances of comorbid ailments like anxiety, depression, sleep disorders, and behavioral problems. Stimulants and other medications are frequently used to treat ADHD, but they can have negative side effects including appetite suppression, sleeplessness, and more severe mental health issues. The fact that people with ADHD are more likely to commit crimes further emphasizes the disorder's wider social and economic effects. ADHD is managed differently over the world; for example, Australia and India have established protocols for diagnosis and therapy. Although pharmacological therapies are frequently employed, non-pharmacological methods including behavioral therapy and cognitive training are becoming more popular due to worries about their long-term effectiveness and potential negative consequences. This essay promotes a comprehensive, tailored strategy for treating ADHD, stressing the significance of addressing the disorder's influencing hereditary and environmental components. This study adds to the continuing discussion about the diagnosis and treatment of ADHD by emphasizing the value of all-encompassing care plans that weigh the advantages and disadvantages of pharmaceutical treatments against non-pharmacological alternatives.